Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.
The equity shares and OCRPS so allotted on preferential basis through private placement shall be subject to lock-in for a period of one year from the date of trading approval.
MDC prices shrunk 1.3% QoQ / 13.4% YoY to Rs33 while chorine and methanol prices increased.
The closing of the transaction is planned for the end of March 2021
The increase amounts for EUR 800 per metric ton.
The foliar spray segment is projected to grow at the highest CAGR between 2020 and 2025.
Huntsman now delivers complete end-to-end system for protection effects
DCW will utilise the funds in refinancing the existing term loans and augment working capital.
NATCO's partner BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks.
Vivimed strategy is to increase its share of Branded products in CIS Markets.
CIM Partners, which will be re-branded as TM Catalyst, will continue its mission of providing independent, insightful and strategic M&A advice to the global chemical industry.
Next step on the journey to reduce the company's environmental footprint
.jpg)
Under the 2021 Share Buyback Program, shares of the company's common stock may be repurchased periodically in open market or privately negotiated transactions.
This adjustment is necessary to address the growing need for continued investment in reliable global supply.
Existing contracts will be honored.
Organically, the core business grew by 7% for the full year.
Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.
EU chemical industry leaders stressed that policy coherence would help the chemical industry attract much-needed investments to further reduce emissions from its manufacturing.
There are immense opportunities for the industry and the government is working to ensure to provide all necessary support.
The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
